{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:23:58Z","timestamp":1761578638813,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12884-019-2205-y","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T07:03:23Z","timestamp":1549263803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Factors associated with common and atypical chromosome abnormalities after positive combined first-trimester screening in Chinese women: a retrospective cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Annisa","family":"Mak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. F.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. L.","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Y. K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9289-6857","authenticated-orcid":false,"given":"K. Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"2205_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/uog.17484","volume":"50","author":"MM Gil","year":"2017","unstructured":"Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50:302\u201314.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2205_CR2","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/gim.2016.97","volume":"18","author":"AR Gregg","year":"2016","unstructured":"Gregg AR, Skotko BG, Benkendorf JL, Monaghan KG, Bajaj K, Best RG, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016;18:1056\u201365.","journal-title":"Genet Med"},{"key":"2205_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/uog.13393","volume":"44","author":"LJ Salomon","year":"2014","unstructured":"Salomon LJ, Alfirevic Z, Audibert F, Kagan KO, Paladini D, Yeo G, et al. ISUOG clinical standards committee. ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice. Ultrasound Obstet Gynecol. 2014;44:122\u20133.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2205_CR4","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/pd.4608","volume":"35","author":"P Benn","year":"2015","unstructured":"Benn P, Borrell A, Chiu RWK, Cuckle H, Dugoff L, Faas B, et al. Position statement from the chromosome abnormality screening committee on behalf of the Board of the International Society for prenatal diagnosis. Prenat Diagn. 2015;35:725\u201334.","journal-title":"Prenat Diagn"},{"key":"2205_CR5","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1097\/AOG.0000000000001051","volume":"126","author":"Committee Opinion No. 640","year":"2015","unstructured":"Committee Opinion No. 640. Cell-free DNA screening for fetal aneuploidy. Obstet Gynecol. 2015;126:e31\u20137.","journal-title":"Obstet Gynecol"},{"key":"2205_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/AOG.0000000000001040","volume":"126","author":"RJ Baer","year":"2015","unstructured":"Baer RJ, Flessel MC, Jelliffe-Pawlowski LL, Goldman S, Hudgins L, Hull AD, et al. Detection rates for aneuploidy by first-trimester and sequential screening. Obstet Gynecol. 2015;126:753\u20139.","journal-title":"Obstet Gynecol"},{"key":"2205_CR7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/pd.4125","volume":"33","author":"S Chetty","year":"2013","unstructured":"Chetty S, Garabedian MJ, Norton ME. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenat Diagn. 2013;33:542\u20136.","journal-title":"Prenat Diagn"},{"key":"2205_CR8","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/AOG.0000000000000275","volume":"123","author":"S Larion","year":"2014","unstructured":"Larion S, Romary L, Mlynarczyk M, Abuhamad AZ, Warsof SL. Changes in prenatal testing trends after introduction of noninvasive prenatal testing. Obstet Gynecol. 2014;123:1303\u201310.","journal-title":"Obstet Gynecol"},{"key":"2205_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000365811","volume":"37","author":"CF Poon","year":"2015","unstructured":"Poon CF, Tse WC, Kou KO, Leung KY. Uptake of noninvasive prenatal testing in Chinese women following positive Down syndrome screening. Fetal Diagn Ther. 2015;37:141\u20137.","journal-title":"Fetal Diagn Ther"},{"key":"2205_CR10","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/gim.2017.55","volume":"19","author":"L Hui","year":"2017","unstructured":"Hui L, Hutchinson B, Poulton A, Halliday J. Population-based impact of noninvasive prenatal screening on screening and diagnostic testing for fetal aneuploidy. Genet Med. 2017;19:1338\u201345.","journal-title":"Genet Med."},{"key":"2205_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/uog.15820","volume":"47","author":"CB Wulff","year":"2016","unstructured":"Wulff CB, Gerds TA, Rode L, Ekelund CK, Petersen OB, Tabor A. Danish fetal medicine study group. Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies. Ultrasound Obstet Gynecol. 2016;47:38\u201344.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2205_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/uog.13270","volume":"43","author":"OB Petersen","year":"2014","unstructured":"Petersen OB, Vogel I, Ekelund C, Hyett J, Tabor A. Danish fetal medicine study group; Danish clinical genetics study group. Potential diagnostic consequences of applying non-invasive prenatal testing: population-based study from a country with existing first-trimester screening. Ultrasound Obstet Gynecol. 2014;43:265\u201371.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2205_CR13","doi-asserted-by":"publisher","first-page":"729.e1","DOI":"10.1016\/j.ajog.2015.12.025","volume":"214","author":"H Shani","year":"2016","unstructured":"Shani H, Goldwaser T, Keating J, Klugman S. Chromosomal abnormalities not currently detected by cell-free fetal DNA: a retrospective analysis at a single center. Am J Obstet Gynecol. 2016;214:729.e1\u2013729.e11.","journal-title":"Am J Obstet Gynecol"},{"key":"2205_CR14","doi-asserted-by":"publisher","first-page":"727.e1","DOI":"10.1016\/j.ajog.2015.12.018","volume":"214","author":"ME Norton","year":"2016","unstructured":"Norton ME, Baer RJ, Wapner RJ, Kuppermann M, Jelliffe-Pawlowski L, Currier RJ. Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities. Am J Obstet Gynecol. 2016;214:727.e1\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"2205_CR15","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1097\/AOG.0000000000000874","volume":"125","author":"A Benachi","year":"2015","unstructured":"Benachi A, Letourneau A, Kleinfinger P, Senat MV, Gautier E, Favre R, et al. Collaborative SEquen\u00e7age a haut debit et aneuploidies (SEHDA) study group. Cell-free DNA analysis in maternal plasma in cases of fetal abnormalities detected on ultrasound examination. Obstet Gynecol. 2015;125:1330\u20137.","journal-title":"Obstet Gynecol"},{"key":"2205_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/uog.18979","volume":"51","author":"A Lindquist","year":"2018","unstructured":"Lindquist A, Poulton A, Halliday J, Hui L. Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing. Ultrasound Obstet Gynecol. 2018;51:487\u201392.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2205_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/uog.14911","volume":"47","author":"R Li","year":"2016","unstructured":"Li R, Wan J, Zhang Y, Fu F, Ou Y, Jing X, et al. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies. Ultrasound Obstet Gynecol. 2016;47:53\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2205_CR18","doi-asserted-by":"publisher","first-page":"227.e1","DOI":"10.1016\/j.ajog.2016.02.030","volume":"215","author":"RB Lefkowitz","year":"2016","unstructured":"Lefkowitz RB, Tynan JA, Liu T, Wu Y, Mazloom AR, Almasri E, et al. Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants. Am J Obstet Gynecol. 2016;215:227.e1\u2013227.e16.","journal-title":"Am J Obstet Gynecol"},{"key":"2205_CR19","doi-asserted-by":"publisher","first-page":"e0159233","DOI":"10.1371\/journal.pone.0159233","volume":"11","author":"H Liu","year":"2016","unstructured":"Liu H, Gao Y, Hu Z, Lin L, Yin X, Wang J, et al. Performance evaluation of NIPT in detection of chromosomal copy number variants using low-coverage whole-genome sequencing of plasma DNA. PLoS One. 2016;11:e0159233.","journal-title":"PLoS One"},{"key":"2205_CR20","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/pd.4640","volume":"35","author":"J Helgeson","year":"2015","unstructured":"Helgeson J, Wardrop J, Boomer T, Almasri E, Paxton WB, Saldivar JS, et al. Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing. Prenat Diagn. 2015;35:999\u20131004.","journal-title":"Prenat Diagn"},{"key":"2205_CR21","doi-asserted-by":"publisher","unstructured":"Pertile MD, Halks-Miller M, Flowers N, Barbacioru C, Kinnings SL, Vavrek D, et al. Rare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental disease. Sci Transl Med. 2017. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.aan1240\n                    \n                  .","DOI":"10.1126\/scitranslmed.aan1240"},{"key":"2205_CR22","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/uog.17548","volume":"51","author":"I Vogel","year":"2018","unstructured":"Vogel I, Petersen OB, Christensen R, Hyett J, Lou S, Vestergaard EM. Chromosomal microarray as a primary diagnostic genomic tool for pregnancies defined as being at increased risk within a population based combined first-trimester screening program. Ultrasound Obstet Gynecol. 2018;51:480\u20136.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2205_CR23","doi-asserted-by":"publisher","first-page":"691.e1","DOI":"10.1016\/j.ajog.2017.10.005","volume":"217","author":"AK Petersen","year":"2017","unstructured":"Petersen AK, Cheung SW, Smith JL, Bi W, Ward PA, Peacock S, et al. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory. Am J Obstet Gynecol. 2017;217:691.e1\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"2205_CR24","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/uog.14795","volume":"45","author":"A Borrell","year":"2015","unstructured":"Borrell A, Stergiotou I. Cell-free DNA testing: inadequate implementation of an outstanding technique. Ultrasound Obstet Gynecol. 2015;45:508\u201311.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2205_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/pd.4945","volume":"36","author":"D Oepkes","year":"2016","unstructured":"Oepkes D, Page-Christiaens GC, Bax CJ, Bekker MN, Bilardo CM, Boon EM, And for the Dutch NIPT consortium, et al. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact. Prenat Diagn. 2016;36:1083\u201390.","journal-title":"Prenat Diagn"},{"key":"2205_CR26","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3109\/14767058.2013.770464","volume":"26","author":"K Song","year":"2013","unstructured":"Song K, Musci TJ, Caughey AB. Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population. J Matern Fetal Neonatal Med. 2013;26:1180\u20135.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2205_CR27","first-page":"2905","volume":"30","author":"E Colosi","year":"2017","unstructured":"Colosi E, D'Ambrosio V, Periti E. First trimester contingent screening for trisomies 21,18,13: is this model cost efficient and feasible in public health system? J Matern Fetal Neonatal Med. 2017;30:2905\u201310.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2205_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/uog.14694","volume":"45","author":"D Wright","year":"2015","unstructured":"Wright D, Wright A, Nicolaides KH. A unified approach to risk assessment for fetal aneuploidies. Ultrasound Obstet Gynecol. 2015;45:48\u201354.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2205_CR29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/01.AOG.0000278570.76392.a6","volume":"110","author":"FM Breathnach","year":"2007","unstructured":"Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, et al. First and second trimester evaluation of risk (FASTER) research consortium. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Obstet Gynecol. 2007;110:651\u20137.","journal-title":"Obstet Gynecol"},{"key":"2205_CR30","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/pd.4584","volume":"35","author":"N T\u00f8rring","year":"2015","unstructured":"T\u00f8rring N, Petersen OB, Becher N, Vogel I, Uldbjerg N. Danish fetal medicine study group; Danish clinical genetics study group. First trimester screening for other trisomies than trisomy 21, 18, and 13. Prenat Diagn. 2015;35:612\u20139.","journal-title":"Prenat Diagn"},{"key":"2205_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/uog.17487","volume":"51","author":"MJA Kenkhuis","year":"2018","unstructured":"Kenkhuis MJA, Bakker M, Bardi F, Fontanella F, Bakker MK, Fleurke-Rozema H, et al. Yield of a 12-13 week scan for the early diagnosis of fetal congenital anomalies in the cell-free DNA era. Ultrasound Obstet Gynecol. 2018;51:463\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2205_CR32","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ajog.2016.04.029","volume":"215","author":"MI Evans","year":"2016","unstructured":"Evans MI, Wapner RJ, Berkowitz RL. Noninvasive prenatal screening or advanced diagnostic testing: caveat emptor. Am J Obstet Gynecol. 2016;215:298\u2013305.","journal-title":"Am J Obstet Gynecol"},{"key":"2205_CR33","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/pd.4666","volume":"35","author":"A Sachs","year":"2015","unstructured":"Sachs A, Blanchard L, Buchanan A, Norwitz E, Bianchi DW. Recommended pre-test counseling points for noninvasive prenatal testing using cell-free DNA: a 2015 perspective. Prenat Diagn. 2015;35:968\u201371.","journal-title":"Prenat Diagn"},{"key":"2205_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12884-015-0636-7","volume":"15","author":"KO Kou","year":"2015","unstructured":"Kou KO, Poon CF, Tse WC, Mak SL, Leung KY. Knowledge and future preference of Chinese women in a major public hospital in Hong Kong after undergoing non-invasive prenatal testing for positive aneuploidy screening: a questionnaire survey. BMC Pregnancy Childbirth. 2015;15:199.","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-019-2205-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-019-2205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T19:19:45Z","timestamp":1580757585000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-019-2205-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2205"],"URL":"https:\/\/doi.org\/10.1186\/s12884-019-2205-y","relation":{},"ISSN":["1471-2393"],"issn-type":[{"type":"electronic","value":"1471-2393"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"6 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Research Ethics Committee of Kowloon Central\/Kowloon East Cluster, Hong Kong, and patient consent was not required because this was a retrospective study. Furthermore, all the participants were anonymous.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"55"}}